Stockreport

ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences

ImageneBio, Inc.  (IMA) 
PDF SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA, “Imagene,” “Company”), a clinical-stage biotechnology company developing therapeutics for p [Read more]